Perspectives by Leerink Partners
Melanie Whittington, PhD, Head of the Leerink Center for Pharmacoeconomics interviews Holly Krasa, CEO of Blue Persimmon Group. In this episode they discuss the recent CPE Exclusive: Cobenfy™ for Adults Living with Schizophrenia, the need for innovation in schizophrenia, and the importance of listening to the stories from people living with schizophrenia.
17 episodes
Comments
0Be the first to comment
Sign up now and become a member of the Perspectives by Leerink Partners community!